Vaccine giant’s shares plunge 10% amid reports of rare side effects, new government restrictions, production struggles
Home Moderna Shares Crater on Huge Revenue Miss, Massive Guidance Cut
Vaccine giant’s shares plunge 10% amid reports of rare side effects, new government restrictions, production struggles